Table 1 Relevant variables to map the field of health care judicialization and equity in Latin America
From: Is the judicialization of health care bad for equity? A scoping review
Variables | Description | Values | ||
|---|---|---|---|---|
Type of study | Title | Title of the study | Text | |
N of Authors | Whether the study is authored by a single author or by multiple authors | Number | ||
Type of Publication | Whether it is a journal article, an entire book or a chapter in an edited volume | 1 Article; 2 Book; 3 Edited Volume; 4 Policy Report | ||
Journal or Book title | Title of the publication | 1 Public health; 2 Law; 3 Other | ||
Year | When it was published | Number | ||
Language | Language in which the study is written | Text | ||
Interdisciplinary | Whether authors belong to one or more disciplines | 1 interdisciplinary; 0 disciplinary | ||
What disciplines the author(s) belong to? | Text | |||
Cases of judicialization | Country | The country or countries the study refers to | Text | |
City/Region | Whether the study focuses on a particular city or region within any given country | Text | ||
Empirical Equity Impact Assesment | Whether the study provides empirical data and analysis to assess impact on equity | 1 provides empirical data and analysis; 0 descriptive with no empirical analysis | ||
Comparative | Whether it compares several countries or regional cases | 1 yes; 0 no | ||
Dynamic perspective | Whether it tracks changes over time —in litigation patterns, type of litigants, etc. | 1 yes; 0 no | ||
Type of Court | Whether the analysis is conducted at lower courts—state courts, city courts, municipal courts— or at the highest court in the land | 1 Highest court; 2 Lower courts; 3 both | ||
Entitlements | Whether the study refers only to medicines or also to other treatments or procedures beyond pharmaceuticals. | 1 Only medicines; 0 other medical treatments as well as medicines | ||
Study design | Methods | Whether the study uses quantitative modeling, descriptive statistics, qualitative or mixed methods | 1 Quantitative (models); 2 Quantitative (descriptive statistics); 3 Qualitative; 4 Mixed | |
Whether the piece has an independent methods section | 1 yes; 0 no | |||
Variables | Whether the following set of variables are analyzed: | Litigants’ demographics | 1 yes; 0 no | |
Type of legal representation | 1 yes; 0 no | |||
Type of claims | 1 yes; 0 no | |||
Prices or costs of litigation | 1 yes; 0 no | |||
Other | Text | |||
Dataset | Whether it works with a data set | 1 yes; 0 no | ||
Where does the data set come from | 1 Totally constructed by the author(s); 2 Provided by the courts/government/litigants but heavily processed by the author(s); 3 Provided by a third party and taken as is | |||
How many observations does the data set have | Number | |||
Effect on equity | Whether the paper suggests that there is a positive, negative, or ambiguous effect of health litigation on equity | 1 Positive; 2 Negative; 3 Ambiguous | ||